191 related articles for article (PubMed ID: 27133377)
1. Activation of AMPK-induced autophagy ameliorates Huntington disease pathology in vitro.
Walter C; Clemens LE; Müller AJ; Fallier-Becker P; Proikas-Cezanne T; Riess O; Metzger S; Nguyen HP
Neuropharmacology; 2016 Sep; 108():24-38. PubMed ID: 27133377
[TBL] [Abstract][Full Text] [Related]
2. Brain-penetrant PQR620 mTOR and PQR530 PI3K/mTOR inhibitor reduce huntingtin levels in cell models of HD.
Singer E; Walter C; Fabbro D; Rageot D; Beaufils F; Wymann MP; Rischert N; Riess O; Hillmann P; Nguyen HP
Neuropharmacology; 2020 Jan; 162():107812. PubMed ID: 31622602
[TBL] [Abstract][Full Text] [Related]
3. Modulating FKBP5/FKBP51 and autophagy lowers HTT (huntingtin) levels.
Bailus BJ; Scheeler SM; Simons J; Sanchez MA; Tshilenge KT; Creus-Muncunill J; Naphade S; Lopez-Ramirez A; Zhang N; Lakshika Madushani K; Moroz S; Loureiro A; Schreiber KH; Hausch F; Kennedy BK; Ehrlich ME; Ellerby LM
Autophagy; 2021 Dec; 17(12):4119-4140. PubMed ID: 34024231
[TBL] [Abstract][Full Text] [Related]
4. AMPK-α1 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington's disease.
Ju TC; Chen HM; Chen YC; Chang CP; Chang C; Chern Y
Biochim Biophys Acta; 2014 Sep; 1842(9):1668-80. PubMed ID: 24946181
[TBL] [Abstract][Full Text] [Related]
5. AMPK activation protects from neuronal dysfunction and vulnerability across nematode, cellular and mouse models of Huntington's disease.
Vázquez-Manrique RP; Farina F; Cambon K; Dolores Sequedo M; Parker AJ; Millán JM; Weiss A; Déglon N; Neri C
Hum Mol Genet; 2016 Mar; 25(6):1043-58. PubMed ID: 26681807
[TBL] [Abstract][Full Text] [Related]
6. Correction of symptoms of Huntington disease by genistein through FOXO3-mediated autophagy stimulation.
Pierzynowska K; Podlacha M; Gaffke L; Rintz E; Wiśniewska K; Cyske Z; Węgrzyn G
Autophagy; 2024 May; 20(5):1159-1182. PubMed ID: 37992314
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease.
Ravikumar B; Vacher C; Berger Z; Davies JE; Luo S; Oroz LG; Scaravilli F; Easton DF; Duden R; O'Kane CJ; Rubinsztein DC
Nat Genet; 2004 Jun; 36(6):585-95. PubMed ID: 15146184
[TBL] [Abstract][Full Text] [Related]
8. AMPK activation restores ischemic post‑conditioning cardioprotection in STZ‑induced type 1 diabetic rats: Role of autophagy.
Zhou B; Leng Y; Lei SQ; Xia ZY
Mol Med Rep; 2017 Sep; 16(3):3648-3656. PubMed ID: 28765969
[TBL] [Abstract][Full Text] [Related]
9. Preventing mutant huntingtin proteolysis and intermittent fasting promote autophagy in models of Huntington disease.
Ehrnhoefer DE; Martin DDO; Schmidt ME; Qiu X; Ladha S; Caron NS; Skotte NH; Nguyen YTN; Vaid K; Southwell AL; Engemann S; Franciosi S; Hayden MR
Acta Neuropathol Commun; 2018 Mar; 6(1):16. PubMed ID: 29510748
[TBL] [Abstract][Full Text] [Related]
10. Gossypol, a novel modulator of VCP, induces autophagic degradation of mutant huntingtin by promoting the formation of VCP/p97-LC3-mHTT complex.
Li XJ; Zhang YY; Fu YH; Zhang H; Li HX; Li QF; Li HL; Tan RK; Jiang CX; Jiang W; Li ZX; Luo C; Lu BX; Dang YJ
Acta Pharmacol Sin; 2021 Oct; 42(10):1556-1566. PubMed ID: 33495516
[TBL] [Abstract][Full Text] [Related]
11. Studying the Role of AMPK in Autophagy.
Krieg S; Lüscher B; Vervoorts J; Dohmen M
Methods Mol Biol; 2018; 1732():373-391. PubMed ID: 29480488
[TBL] [Abstract][Full Text] [Related]
12. HIPK3 modulates autophagy and HTT protein levels in neuronal and mouse models of Huntington disease.
Fu Y; Sun X; Lu B
Autophagy; 2018; 14(1):169-170. PubMed ID: 29130397
[TBL] [Abstract][Full Text] [Related]
13. Modulation of mTOR and CREB pathways following mGluR5 blockade contribute to improved Huntington's pathology in zQ175 mice.
Abd-Elrahman KS; Ferguson SSG
Mol Brain; 2019 Apr; 12(1):35. PubMed ID: 30961637
[TBL] [Abstract][Full Text] [Related]
14. Compound C induces protective autophagy in cancer cells through AMPK inhibition-independent blockade of Akt/mTOR pathway.
Vucicevic L; Misirkic M; Janjetovic K; Vilimanovich U; Sudar E; Isenovic E; Prica M; Harhaji-Trajkovic L; Kravic-Stevovic T; Bumbasirevic V; Trajkovic V
Autophagy; 2011 Jan; 7(1):40-50. PubMed ID: 20980833
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rb3 provides protective effects against cisplatin-induced nephrotoxicity via regulation of AMPK-/mTOR-mediated autophagy and inhibition of apoptosis in vitro and in vivo.
Xing JJ; Hou JG; Ma ZN; Wang Z; Ren S; Wang YP; Liu WC; Chen C; Li W
Cell Prolif; 2019 Jul; 52(4):e12627. PubMed ID: 31094028
[TBL] [Abstract][Full Text] [Related]
16. Metformin suppresses adipogenesis through both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms.
Chen SC; Brooks R; Houskeeper J; Bremner SK; Dunlop J; Viollet B; Logan PJ; Salt IP; Ahmed SF; Yarwood SJ
Mol Cell Endocrinol; 2017 Jan; 440():57-68. PubMed ID: 27856330
[TBL] [Abstract][Full Text] [Related]
17. Glyceraldehyde-3-Phosphate Dehydrogenase Facilitates Macroautophagic Degradation of Mutant Huntingtin Protein Aggregates.
Chaudhary S; Dhiman A; Dilawari R; Chaubey GK; Talukdar S; Modanwal R; Patidar A; Malhotra H; Raje CI; Raje M
Mol Neurobiol; 2021 Nov; 58(11):5790-5798. PubMed ID: 34406601
[TBL] [Abstract][Full Text] [Related]
18. Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease.
Luis-Ravelo D; Estévez-Silva H; Barroso-Chinea P; Afonso-Oramas D; Salas-Hernández J; Rodríguez-Núñez J; Acevedo-Arozena A; Marcellino D; González-Hernández T
Exp Neurol; 2018 Jan; 299(Pt A):137-147. PubMed ID: 29056363
[TBL] [Abstract][Full Text] [Related]
19. Assessment of chloroquine treatment for modulating autophagy flux in brain of WT and HD mice.
Vodicka P; Lim J; Williams DT; Kegel KB; Chase K; Park H; Marchionini D; Wilkinson S; Mead T; Birch H; Yates D; Lyons K; Dominguez C; Beconi M; Yue Z; Aronin N; DiFiglia M
J Huntingtons Dis; 2014; 3(2):159-74. PubMed ID: 25062859
[TBL] [Abstract][Full Text] [Related]
20. AMPK activation protects astrocytes from hypoxia‑induced cell death.
Barialai L; Strecker MI; Luger AL; Jäger M; Bruns I; Sittig ACM; Mildenberger IC; Heller SM; Delaidelli A; Lorenz NI; Voss M; Ronellenfitsch MW; Steinbach JP; Burger MC
Int J Mol Med; 2020 May; 45(5):1385-1396. PubMed ID: 32323755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
